medigraphic.com
Revista de Enfermería del Instituto Mexicano del Seguro Social

2013, Number 2

<< Back Next >>

Rev Enferm IMSS 2013; 21 (2)

Clinical Practice Guidelines Nursing Interventions in the patient with Preeclampsia / Eclampsia

Barrera-Cruz A, Mancilla-García ME, Román-Maeda SY, Rodríguez-Loreto E, Villaláz-Ureña A

Language: Spanish
References: 58
Page: 91-104
PDF size: 268.54 Kb.


ABSTRACT

Introduction: preeclampsia is a major pregnancy-associated hypertensive disease, which complicates between 7 to 10% of pregnant women. This multifactorial disease of unknown etiology and irreversible involves multiple organs and it is the cause of a signifi cant proportion of maternal and perinatal deaths.
Objective: to provide nursing staff a set of recommendations based on the best scientifi c evidence available, to identify risk factors, warning signs and symptoms of preeclampsia during prenatal and postpartum care of patient with preeclampsia / eclampsia.
Methods: structured clinical questions were raised in relation to risk factors, diagnosis, prenatal and postpartum care of patient with preeclampsia / eclampsia. The process of developing the guide was mixed (de novo adaptation/development). The information search was made on specifi c sites of Clinical Practice Guidelines and PubMed, limited to papers published in the last 10 years, in English or Spanish. MeSH terms were used based on keywords: preeclampsia, nursing intervention, preeclampsia risk, preeclampsia prevention, postpartum preeclampsia. The strength of the evidence (E) and the grade of recommendation (G) is expressed in each of the interventions according to established classifi cation systems.
Conclusion: preeclampsia is a serious public health problem in Mexico, which increases maternal and perinatal morbidity and mortality, as well as causing serious socio-economic implications. Early identifi cation of maternal and environmental risk factors for preeclampsia / eclampsia, may decrease the odds of developing this syndrome and prevent progression to more severe forms.


REFERENCES

  1. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102(1):181-92.

  2. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785-99.

  3. Uzan J. Carbonnel M. Piconne O. Asmar R. Ayoubi JM. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011;7:467-74.

  4. Velasco Murillo V. Navarrete Hernández E. Mortalidad materna en el IMSS, 1991-2005. Un periodo de cambios. Rev Med Inst Mex Seguro Soc. 2006;44(Supl 1):S121-128.

  5. Briceño Pérez C. Briceño Sanabria L. Conducta obstétrica basada en evidencias. Preeclampsia leve: manejo expectante, ¿hospitalario o ambulatorio? Ginecol Obstet Mex. 2006;74(10):537- 45. [En línea] http://www.nietoeditores.com.mx/download/ gineco/2006/Octubre%202006/Ginecol%20Obstet%20 Mex%202006-74-537-45.pdf [Consultado 13/06/2012]

  6. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183(1):S1-S22.

  7. Chandiramani M, Shennan A. Hypertensive disorders of pregnancy: a UK based perspective. Curr Opin Obstet Gynecol. 2008;20(2):96-101.

  8. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066-74.

  9. Bouvier-Colle MH. Maternal mortality in developing countries: statistical data and improvement in obstetrical care. Med Trop (Mars). 2003;63(4-5):358-65.

  10. Tsu VD, Shane B. New and underutilized technologies to reduce maternal mortality call to action from a Bellagio workshop. Int J Gynaecol Obstet. 2004;85(Suppl. 1):S83-93.

  11. Sánchez Rodríguez EN, Nava Salazar S, Moran C, Romero Arauz JF, Cerbón Cervantes MA. Estado actual de la preeclampsia en México: de lo epidemiológico a sus mecanismos moleculares. Rev Invest Clin. 2010;62(3):252-60.

  12. Pennington KA, Schlitt JM, Jackson DL, Schulz LC, Schust DJ. Preeclampsia: multiple approaches for a multifactorial disease. Dis Model Mech. 2012;5(1): 9-18.

  13. Milne F, Redman C, Walker J, Baker P, Black R, Blincowe J, Cooper C. Et al. Assessing the onset of pre-eclampsia in the hospital day unit: summary of the pre-eclampsia guideline (PRECOG II). BMJ. 2009;339:b3129.

  14. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330(7491):565.

  15. Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA. 2002;287(24):3183-6.

  16. Von Dadelszen P, Magee L. What matters in preeclampsia are the associated adverse outcomes: the view from Canada? Curr Opin Obstet Gynecol. 2008;20(2):110-5.

  17. Secretaria de Salud (México). Centro Nacional de Equidad de Género y Salud Reproductiva. Diagnóstico y manejo de la preeclampsia/eclampsia. Lineamiento técnico. 4° ed., México: La Secretaria; 2007. [En línea] http://www. salud.gob.mx/unidades/cdi/documentos/PREECLAMPSIA_ ECLAMPSIA_lin-2007.pdf [Consultado 05/03/2012]

  18. Leis Márquez MT, Rodríguez Bosch MR, García Lopez MA, Colegio Mexicano de Especialistas en Ginecología y Obstetricia. Guías de práctica clínica. Diagnóstico y tratamiento de la preeclampsia- eclampsia. Ginecol Obstet Mex. 2010;78(6):S461- S525. [En línea] http://www.medigraphic.com/pdfs/ginobsmex/ gom-2010/gom106f.pdf [Consultado 12/03/2012].

  19. Velasco Murillo V, Navarrete Hernández E, Hernández Alemán F, Anaya Coeto S, Pozos Cavanzo JL, Chavarría Olarte ME. Mortalidad materna en el IMSS. Resultados iniciales de una intervención para su reducción. Cir Cir. 2004;72(4):293- 300. [En línea] http://www.medigraphic.com/pdfs/circir/cc- 2004/cc044g.pdf [Consultado 25/02/2012].

  20. Torres Arreola LP, Peralta Pedrero ML, Viniegra Osorio A, Valenzuela Flores AA, Echevarria Zuno S, Sandoval Castellanos FJ. Proyecto para el desarrollo de guías de práctica clínica en el Instituto Mexicano del Seguro Social. Rev Med Inst Mex Seguro Soc. 2010;48(6):661-672.

  21. Organización Panamericana de la Salud. Lineamientos y directrices de enfermería para la mejoría de la calidad de la atención prenatal en embarazos de bajo riesgo en América Latina y el Caribe. Washington, D.C: OPS; 2004. [En línea] http://www1.paho.org/Spanish/AD/FCH/WM/ Prenatalcare Manualesp.pdf [Consultado 02/04/2012].

  22. Thangaratinam S, Gallos ID, Meah N, Usman S, Ismail KM, Khan KS, TIPPS (Tests in Prediction of Pre-eclampsia's Severity) Review Group. How accurate are maternal symptoms in predicting impending complications in women with preeclampsia? A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2011;90(6):564-73.

  23. Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet. 2001;357(9251):209-15.

  24. Thangaratinam S, Coomarasamy A, O'Mahony F, Sharp S, Zamora J, Khan KS, Ismail KM. Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review. BMC Med. 2009;7:10.

  25. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol. 2008;112(2 Pt 1):359-72.

  26. Barra S, Cachulo Mdo C, Providência R, Leitão-Marques A. Hipertensao arterial na gravida: o atual estado da arte. Rev Port Cardiol. 2012;31(6):425-32.

  27. Elu MC, Santos PE. Mortalidad materna: una tragedia evitable. Perinatol Reprod Hum. 2004;18(1):44-52. [En línea] http://new. medigraphic.com/cgi-bin/resumen.cgi?IDREVISTA=76&IDARTIC ULO=21254&IDPUBLICACION=2158 [Consultado 05/03/2012]

  28. Magee LA, Helewa M, Moutquin JM, von Dadelszen P, Hypertension Guideline Committee, Strategic Training Initiative in Research in the Reproductive Health Sciences (STIRRHS) Scholars. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can. 2008;30(3 Suppl):S1-48.

  29. American College of Obstetricians and Gynecologists (ACOG) Practice bulletin: Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol. 2002;99(1):159–167.

  30. National Institute for Health and Clinical Excellence (England). National Collaborating Centre for Women’s and Children’s Health. Antenatal care Routine care for the healthy pregnant woman This guideline partially updates and replaces. NICE clinical guideline 6. [En línea] http://www.nice.org.uk/nicemedia/ pdf/CG062NICEguideline.pdf [Consultado 05/03/2012].

  31. Association of Ontario Midwives. Clinical Practice Guideline No.15. Hypertensive disorders of pregnancy. Toronto: AOM;2012. 1-44. [En línea] http://www.aom.on.ca/fi les/ Health_Care_Professionals/Clinical_Practice_Guidelines/ No_15_CPG_HDP_062612.pdf [Consultado 05/05/2012].

  32. Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev. 2010;17;(3):CD005182.

  33. Villanueva Egan LA, Collado Peña SP. Conceptos actuales sobre la preeclampsia-eclampsia. Rev Fac Med UNAM. 2007;50(2):57-61. [En línea] http://www.medigraphic.com/ pdfs/facmed/un-2007/un072b.pdf [Consultado 13/04/2012].

  34. Bergel E, Carroli G, Althabe F. Ambulatory versus conventional methods for monitoring blood pressure during pregnancy. Cochrane Database Syst Rev. 2002;(2):CD001231.

  35. Milne F, Redman C, Walker J, Baker P, Bradley J, Cooper C, de Swiet M, Et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ. 2005;330(7491):576-80.

  36. Registered Nurses' Association of Ontario. Nursing Best Practice Guideline. Shaping the future of Nursing. Nursing Management of Hypertension. 2005; Rev. 2009 [En línea] http://rnao.ca/sites/rnao-ca/fi les/Nursing_Management_ of_Hypertension.pdf [Consultado 02/03/2012].

  37. NANDA International. Diagnósticos enfermeros: Defi niciones y clasifi cación 2009-2011. Barcelona; Elsevier España; 2010.

  38. Bulechek GM, Butcher HK, McCloskey JC (ed). Clasifi cación de Intervenciones de Enfermería (NIC). 5a ed. Barcelona: Elsevier España; 2009.

  39. Ackley BJ, Ladwig GB. Manual de diagnósticos de enfermería: guía para la planifi cación de los cuidados. 7a ed. Madrid: Elsevier España, 2007.

  40. Meher S, Duley L. Exercise or other physical activity for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2006;(2):CD005942.

  41. National Institute for Health and Clinical Excellence (England). Hypertension in pregnancy. The management of hypertensive disorders during pregnancy. NICE clinical guideline 107. 2010; rev. 2011. [En línea] http://www.nice.org.uk/nicemedia/ live/13098/50418/50418.pdf [Consultado 02/03/2012].

  42. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2007;(1):CD002252.

  43. Salles AM, Galvao TF, Silva MT, Motta LC, Pereira MG. Antioxidants for preventing preeclampsia: a systematic review. Scientifi cWorldJournal. 2012:243476.

  44. Rumbold A, Duley L, Crowther CA, Haslam RR. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev. 2008;(1):CD004227.

  45. Meher S, Duley L. Nitric oxide for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;(2):CD006490.

  46. Imdad A. Jabeen A. Bhutta ZA. Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: a meta-analysis of studies from developing countries. BMC Public Health. 2011;11(Suppl 3):S3-S18.

  47. Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2010;(8):CD001059.

  48. Conde-Agudelo A. Romero R. Kusanovic JP. Hassan SS. Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011;204(6):503.e1-12.

  49. Roberge S, Villa P, Nicolaides K, Giguere Y, Vainio M, Bakthi A, Ebrashy A, Et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther. 2012;31(3):141-6.

  50. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;(2):CD004659.

  51. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2006;(3):CD001449.

  52. McDonald SD. Lutsiv O. Dzaja N. Duley L. A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use. Int J Gynaecol Obstet. 2012;118(2):90-96.

  53. Duley L, Gülmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2010;(11):CD000025.

  54. Duley L, Henderson-Smart DJ, Chou D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev. 2010;(10):CD000128.

  55. Shekelle PG. Woolf SH. Eccles M. Grimshaw J. Clinical guidelines: developing guidelines. BMJ. 1999;318(7183):593-6.

  56. Turner JA. Diagnosis and management of pre-eclampsia: an update. Int J Womens Health. 2010;2:327-337.

  57. Leeman L. Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician. 2008;78(1):93-100.

  58. Duley L, Henderson-Smart DJ, Walker GJ, Chou D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev. 2010;(12):CD000127.




2020     |     www.medigraphic.com